A new class of compounds inhibiting de-O-glycosylation of proteins has been identified. Highly substituted diaminocyclopentanes are impressively selective reversible non-transition state O-β-N-acetyl-d-glucosaminidase (O-GlcNAcase) inhibitors. The ease of preparative access and remarkable biological activities provide highly viable leads for the development of anti-tau-phosphorylation agents with a view to eventually ameliorating Alzheimer's disease.
Keywords: Alzheimer’s disease; Diaminocyclopentane; Glycosidase inhibition; O-GlcNAcase.
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.